As one of the leading causes of death and morbidity globally, cancer is a complex illness that can be brought on by environmental or genetic factors. Cells proliferate out of control in cancer, resulting in the growth of a tumor-like aberrant mass of cells. New blood vessels and metastases that have already migrated to other places of the body are signs that the main tumor is still growing. A global issue is identifying and treating cancer. A cancer diagnosis can be made through image methods like mammography, magnetic resonance imaging, computer tomography, X-rays, ultrasound imaging, mass spectroscopy, or biomarker detection.
To improve the life expectancy and quality of life of cancer patients, early detection and precision treatment are now viable approaches. On the one hand, it is critical to perform quick, affordable, and trustworthy regular screening for cancer markers in people's blood before the emergence of symptoms suggesting the growth of a tumor.
Immunological methods and histological diagnostic techniques are examples of conventional approaches to tumor detection; on the other hand, they generally need expensive analysis, complicated procedures, long turnaround times, specialized staff, and high false positive rates. The other issue is that a rapid diagnosis and prognosis for malignant tumors is difficult to acquire with these tests. Modern analytical science relies heavily on electrochemical technology as a means of electroanalysis generating new screening tools, making the analysis possible at very low concentration levels without or with minimum pre-treatment of the samples.
In addition to successfully differentiating tumor cells from normal cells, the electrochemical technique has also achieved targeted detection of localized tumor cells and circulating tumor cells, thanks to its rapid detection, high sensitivity (single cell), and specificity in the detection of tumor cells. In clinical medicine, electrochemical biosensors are extremely useful for the early detection, staging, and prognosis of malignancies.
The aim of the current Research Topic is to present the new electrochemical tools and methods based on (bio)sensors that are able to detect (possible) biomarkers for early screening and detection of cancer. We welcome the submission of Original Research, Review, Mini Review, and Perspective articles on themes including, but not limited to:
- New electrochemical tools for highly selective and sensitive assay of biomarkers from different classes such as proteins, cells, genes etc.
- New approaches for cancer screening using electrochemical (bio)sensors
- Therapeutic strategies involving electrochemical (bio) sensors
- Developing new materials for (bio) sensor’s design and assay of cancer
Keywords:
Electrochemical sensors, biosensors, cancer screening, Biomarkers
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
As one of the leading causes of death and morbidity globally, cancer is a complex illness that can be brought on by environmental or genetic factors. Cells proliferate out of control in cancer, resulting in the growth of a tumor-like aberrant mass of cells. New blood vessels and metastases that have already migrated to other places of the body are signs that the main tumor is still growing. A global issue is identifying and treating cancer. A cancer diagnosis can be made through image methods like mammography, magnetic resonance imaging, computer tomography, X-rays, ultrasound imaging, mass spectroscopy, or biomarker detection.
To improve the life expectancy and quality of life of cancer patients, early detection and precision treatment are now viable approaches. On the one hand, it is critical to perform quick, affordable, and trustworthy regular screening for cancer markers in people's blood before the emergence of symptoms suggesting the growth of a tumor.
Immunological methods and histological diagnostic techniques are examples of conventional approaches to tumor detection; on the other hand, they generally need expensive analysis, complicated procedures, long turnaround times, specialized staff, and high false positive rates. The other issue is that a rapid diagnosis and prognosis for malignant tumors is difficult to acquire with these tests. Modern analytical science relies heavily on electrochemical technology as a means of electroanalysis generating new screening tools, making the analysis possible at very low concentration levels without or with minimum pre-treatment of the samples.
In addition to successfully differentiating tumor cells from normal cells, the electrochemical technique has also achieved targeted detection of localized tumor cells and circulating tumor cells, thanks to its rapid detection, high sensitivity (single cell), and specificity in the detection of tumor cells. In clinical medicine, electrochemical biosensors are extremely useful for the early detection, staging, and prognosis of malignancies.
The aim of the current Research Topic is to present the new electrochemical tools and methods based on (bio)sensors that are able to detect (possible) biomarkers for early screening and detection of cancer. We welcome the submission of Original Research, Review, Mini Review, and Perspective articles on themes including, but not limited to:
- New electrochemical tools for highly selective and sensitive assay of biomarkers from different classes such as proteins, cells, genes etc.
- New approaches for cancer screening using electrochemical (bio)sensors
- Therapeutic strategies involving electrochemical (bio) sensors
- Developing new materials for (bio) sensor’s design and assay of cancer
Keywords:
Electrochemical sensors, biosensors, cancer screening, Biomarkers
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.